NASDAQ:FNCH

Finch Therapeutics Group News Headlines

$12.66
-0.27 (-2.09 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.50
▼
$13.63
50-Day Range
$12.93
▼
$21.32
52-Week Range
$12.50
▼
$22.50
Volume59,181 shs
Average Volume151,329 shs
Market Capitalization$596.86 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Finch Therapeutics Group (NASDAQ FNCH) News Headlines Today

SourceHeadline
Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care ConferenceFinch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference
finance.yahoo.com - May 6 at 11:28 AM
Finch Therapeutics Group (NASDAQ:FNCH) Hits New 1-Year Low at $13.38Finch Therapeutics Group (NASDAQ:FNCH) Hits New 1-Year Low at $13.38
americanbankingnews.com - May 5 at 3:08 PM
Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Up to $13.60Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Up to $13.60
americanbankingnews.com - April 28 at 3:18 PM
Finch Therapeutics Group (NASDAQ:FNCH) Reaches New 12-Month Low at $13.41Finch Therapeutics Group (NASDAQ:FNCH) Reaches New 12-Month Low at $13.41
americanbankingnews.com - April 27 at 2:40 PM
Finch Therapeutics Appoints Susan E. Graf to Board of DirectorsFinch Therapeutics Appoints Susan E. Graf to Board of Directors
finance.yahoo.com - April 27 at 8:17 AM
Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Down to $14.23Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Down to $14.23
americanbankingnews.com - April 22 at 12:00 PM
Finch Therapeutics Group (NASDAQ:FNCH) Shares Down 8.1% Finch Therapeutics Group (NASDAQ:FNCH) Shares Down 8.1%
americanbankingnews.com - April 21 at 11:43 AM
Finch Therapeutics Group, Inc.s Quiet Period Will Expire on April 28th (NASDAQ:FNCH)Finch Therapeutics Group, Inc.'s Quiet Period Will Expire on April 28th (NASDAQ:FNCH)
americanbankingnews.com - April 21 at 1:14 AM
Finch Therapeutics Group (NASDAQ:FNCH) Sets New 12-Month Low at $15.05Finch Therapeutics Group (NASDAQ:FNCH) Sets New 12-Month Low at $15.05
americanbankingnews.com - April 20 at 12:50 PM
Finch Therapeutics Group (NASDAQ:FNCH) Receives New Coverage from Analysts at Jefferies Financial GroupFinch Therapeutics Group (NASDAQ:FNCH) Receives New Coverage from Analysts at Jefferies Financial Group
americanbankingnews.com - April 19 at 12:35 PM
Finch Therapeutics Group (NASDAQ:FNCH) Now Covered by Evercore ISIFinch Therapeutics Group (NASDAQ:FNCH) Now Covered by Evercore ISI
americanbankingnews.com - April 19 at 12:35 PM
Finch Therapeutics Group (NASDAQ:FNCH) Now Covered by Analysts at Bank of AmericaFinch Therapeutics Group (NASDAQ:FNCH) Now Covered by Analysts at Bank of America
americanbankingnews.com - April 19 at 11:32 AM
Finch Therapeutics to Participate in the Jefferies Microbiome-Based Therapeutics SummitFinch Therapeutics to Participate in the Jefferies Microbiome-Based Therapeutics Summit
markets.businessinsider.com - April 15 at 8:01 AM
Jefferies Financial Group Weighs in on Finch Therapeutics Group, Inc.s Q1 2021 Earnings (NASDAQ:FNCH)Jefferies Financial Group Weighs in on Finch Therapeutics Group, Inc.'s Q1 2021 Earnings (NASDAQ:FNCH)
americanbankingnews.com - April 15 at 6:34 AM
Highway 400 closed between Highway 401 and Finch Avenue due to fire at fertilizer factoryHighway 400 closed between Highway 401 and Finch Avenue due to fire at fertilizer factory
msn.com - April 14 at 3:45 PM
Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Down to $17.00Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Down to $17.00
americanbankingnews.com - April 14 at 1:00 PM
Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Up to $17.10Finch Therapeutics Group (NASDAQ:FNCH) Shares Gap Up to $17.10
americanbankingnews.com - April 13 at 11:10 AM
Finch Therapeutics Group (NASDAQ:FNCH) Research Coverage Started at Evercore ISIFinch Therapeutics Group (NASDAQ:FNCH) Research Coverage Started at Evercore ISI
americanbankingnews.com - April 13 at 10:30 AM
Finch Therapeutics Group (NASDAQ:FNCH) Now Covered by Jefferies Financial GroupFinch Therapeutics Group (NASDAQ:FNCH) Now Covered by Jefferies Financial Group
americanbankingnews.com - April 13 at 8:34 AM
Bank of America Begins Coverage on Finch Therapeutics Group (NASDAQ:FNCH)Bank of America Begins Coverage on Finch Therapeutics Group (NASDAQ:FNCH)
americanbankingnews.com - April 13 at 8:00 AM
29 finches sealed inside hair rollers discovered in mans luggage as he arrives in US29 finches sealed inside hair rollers discovered in man's luggage as he arrives in US
msn.com - March 31 at 8:44 AM
News for Finch Therapeutics Group Inc Registered ShsNews for Finch Therapeutics Group Inc Registered Shs
markets.businessinsider.com - March 26 at 1:50 PM
This page was last updated on 5/8/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.